Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Recruiting now

Conditions studied: Crohn Disease (CD), Ulcerative Colitis (UC)

In brief

Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.

Key facts

Study ID

NCT07621783

Run by

Imelda GI Clinical Research Center

People needed

100

Starts

2026-05-01

Expected to finish

2026-12-31

Last updated by the study team

2026-06-02

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years
• Patient with confirmed diagnosis of IBD
• Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)/ulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice
• willing to provide informed consent

You may not qualify if…

• Patient with IBD unspecified
• Patient with ileo- or colostomy
• Patient with total colectomy
• Women that are pregnant

Where it is running

• Imelda General Hospital — Bonheiden, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.